These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4077737)

  • 1. Esperamicins, a novel class of potent antitumor antibiotics. I. Physico-chemical data and partial structure.
    Konishi M; Ohkuma H; Saitoh K; Kawaguchi H; Golik J; Dubay G; Groenewold G; Krishnan B; Doyle TW
    J Antibiot (Tokyo); 1985 Nov; 38(11):1605-9. PubMed ID: 4077737
    [No Abstract]   [Full Text] [Related]  

  • 2. Production and isolation of two novel esperamicins in a chemically defined medium.
    Lam KS; Veitch JA; Golik J; Rose WC; Doyle TW; Forenza S
    J Antibiot (Tokyo); 1995 Dec; 48(12):1497-501. PubMed ID: 8557609
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of DNA cleavage specificity by esperamicins.
    Lu M; Guo Q; Krishnan B; Golik J; Rosenberg IE; Doyle TW; Kallenbach NR
    J Biomol Struct Dyn; 1991 Oct; 9(2):285-98. PubMed ID: 1741964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esperamicins, a class of potent antitumor antibiotics: mechanism of action.
    Long BH; Golik J; Forenza S; Ward B; Rehfuss R; Dabrowiak JC; Catino JJ; Musial ST; Brookshire KW; Doyle TW
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):2-6. PubMed ID: 2643098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new macromolecular antitumor antibiotic, C-1027. II. Isolation and physico-chemical properties.
    Otani T; Minami Y; Marunaka T; Zhang R; Xie MY
    J Antibiot (Tokyo); 1988 Nov; 41(11):1580-5. PubMed ID: 3198492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gilvocarcins, new antitumor antibiotics. 2. Structural elucidation.
    Takahashi K; Yoshida M; Tomita F; Shirahata K
    J Antibiot (Tokyo); 1981 Mar; 34(3):271-5. PubMed ID: 7275808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trioxacarcins, novel antitumor antibiotics. II. Isolation, physico-chemical properties and mode of action.
    Tamaoki T; Shirahata K; Iida T; Tomita F
    J Antibiot (Tokyo); 1981 Dec; 34(12):1525-30. PubMed ID: 6800996
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychlorothricin, a new antitumor antibiotic.
    Yamamoto I; Nakagawa M; Hayakawa Y; Adachi K; Kobayashi E
    J Antibiot (Tokyo); 1987 Oct; 40(10):1452-4. PubMed ID: 3680011
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytosine methylation enhances DNA damage produced by groove binding and intercalating enediynes: studies with esperamicins A1 and C.
    Mathur P; Xu J; Dedon PC
    Biochemistry; 1997 Dec; 36(48):14868-73. PubMed ID: 9398209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Swalpamycin, a new macrolide antibiotic. II. Structure elucidation.
    Chatterjee S; Reddy GC; Franco CM; Rupp RH; Ganguli BN; Fehlhaber HW; Kogler H
    J Antibiot (Tokyo); 1987 Oct; 40(10):1368-74. PubMed ID: 3680002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antitumor antibiotics, saptomycins. II. Isolation, physico-chemical properties and structure elucidation.
    Abe N; Enoki N; Nakakita Y; Uchida H; Nakamura T; Munekata M
    J Antibiot (Tokyo); 1993 Oct; 46(10):1536-49. PubMed ID: 8244881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APHE-1 and APHE-2, two new antimicrobial and cytotoxic antibiotics. II. Physico-chemical properties and structure elucidation.
    Fidalgo ML; Arias MS; Soliveri J; Arias ME
    J Antibiot (Tokyo); 1992 Nov; 45(11):1759-62. PubMed ID: 1468983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.
    Hensens OD; Goldberg IH
    J Antibiot (Tokyo); 1989 May; 42(5):761-8. PubMed ID: 2524463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A.
    Weiss U; Yoshihira K; Highet RJ; White RJ; Wei TT
    J Antibiot (Tokyo); 1982 Sep; 35(9):1194-201. PubMed ID: 7142022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-1027 enediyne chromophore: presence of another active form and its chemical structure.
    Otani T; Yoshida K; Sasaki T; Minami Y
    J Antibiot (Tokyo); 1999 Apr; 52(4):415-21. PubMed ID: 10395278
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure of decilorubicin.
    Ishii K; Nishimura Y; Naganawa H; Kondo S; Umezawa H
    J Antibiot (Tokyo); 1984 Apr; 37(4):344-53. PubMed ID: 6704208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for degradation of esperamicin A1 with thiol confirmed by fast-atom bombardment mass spectrometry.
    Takayama M; Nomura T; Konishi M
    Rapid Commun Mass Spectrom; 1991 May; 5(5):252-4. PubMed ID: 1804416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fortimicins A and B, new aminoglycoside antibiotics. III. Structural identification.
    Egan RS; Stanaszek RS; Cirovic M; Mueller SL; Tadanier J; Martin JR; Collum P; Goldstein AW; De Vault RL; Sinclair AC; Fager EE; Mitscher LA
    J Antibiot (Tokyo); 1977 Jul; 30(7):552-63. PubMed ID: 893225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankinomycin, a potent antitumor antibiotic.
    Sato Y; Watabe H; Nakazawa T; Shomura T; Yamamoto H; Sezaki M; Kondo S
    J Antibiot (Tokyo); 1989 Jan; 42(1):149-52. PubMed ID: 2590276
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on cochleamycins, novel antitumor antibiotics. II. Physico-chemical properties and structure determination.
    Shindo K; Iijima H; Kawai H
    J Antibiot (Tokyo); 1996 Mar; 49(3):244-8. PubMed ID: 8626238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.